BUTTERFLY NEEDLES MARKET ANALYSIS

The global butterfly needles market size is expected to reach US$ 3.87 Bn by 2030, from US$ 2.16 Bn in 2023, exhibiting a compounded annual growth rate (CAGR) of 8.7% during the forecast period. Butterfly needles are winged steel needles used for drawing blood or intravenous therapy. Rising prevalence of chronic diseases and increasing demand for blood transfusions is expected to drive the market growth of the butterfly needles marker. The butterfly needles market is segmented by needle length, gauge size, end user and region. By end user, the hospitals segment is expected to grow significantly due to increasing demand for blood transfusions and others.

Butterfly needles which are also referred to as winged infusion sets or scalp vein sets due to the plastic wings flanking the hollow needle serves as tools for extracting blood or delivering medications into veins. These devices find frequent application in drawing blood or administering treatments to infants, young children, and the elderly.

Global Butterfly Needles Market Regional Insights

•  North America is expected to be the largest market for butterfly needles market during the forecast period, accounting for over 39.5% of the market share in 2023. The growth of the market in North America is due to the high adoption of advanced medical technologies and presence of leading manufacturers in the region.
•  The Europe market is expected to be the second-largest market for butterfly needles market, accounting for over 28.2% of the market share in 2023. The growth of the market is due to the rising prevalence of chronic diseases and favorable government initiatives in the region.
• The Asia Pacific market is expected to be the fastest-growing market for butterfly needles market, with a CAGR of over 19.3% during the forecast period. The growth of the market in Asia Pacific is due to the improving healthcare infrastructure and increasing healthcare expenditure in the region.

Figure 1. Global Butterfly Needles Market Share (%), By Region, 2023

To learn more about this report, request a free sample copy

Analyst Views:

• The butterfly needles market is expected to grow steadily over the forecast period driven by increasing prevalence of chronic diseases and rising geriatric population worldwide. Growing demand for safety-engineered IV insertion devices from clinics and hospitals are also expected to propel the market growth. North America currently dominates the butterfly needles market owing to high awareness regarding aseptic and proper techniques for IV insertion. Asia Pacific is anticipated to be the fastest growing market due to improving healthcare infrastructure and rising medical tourism in the region
• However, availability of alternative IV insertion devices like saline lock needles and low dead space syringes may hamper the market growth to some extent. Increased preferences towards needle-free drug delivery systems like wearable and patch pumps over traditional needles are also a major challenge for butterfly needles manufacturers. Stringent regulations regarding safety and sterility of medical needles pose additional difficulties in market expansion. Lack of trained healthcare professionals for proper insertion technique in developing nations can further restrain the butterfly needles adoption
• Key players operating in the butterfly needles market should focus on expanding their distributor networks in emerging countries. Manufacturers must enhance product development for pediatric sizes and more user-friendly designs. Companies could also leverage opportunities in home healthcare services by introducing smaller gauges and ready to use packaging formats. Strategic collaborations with hospitals for competitive tendering will aid in further market penetration. Educating healthcare workers on appropriate use through awareness programs

Global Butterfly Needles Market Drivers

• Increasing prevalence of chronic diseases driving demand for butterfly needles: Rising prevalence of chronic diseases such as diabetes, cancer, and kidney disorders is increasing the demand for regular diagnosis tests and treatments, which is driving the growth of the butterfly needles market. In 2020, according to the World Health Organizations (WHO), chronic diseases accounted for 60% of all deaths worldwide.
• Growing demand for blood transfusions and blood donations: Increasing number of surgical procedures, road accidents, traumas, and anemia cases is escalating the demand for blood transfusions. This is fueling the adoption of butterfly needles for efficient blood sample collection. In 2021, according to the report by World Health Organizations (WHO), 118.5 Mn blood donations are collected globally every year.

• Rise in hospitalization rates and need for effective venipuncture: Rising hospitalization rates due to the increasing burden of chronic diseases is leading to high demand for intravenous needles and infusion pumps. Butterfly needles enable easy and painless venipuncture as compared to traditional needles.

• Technological advancements in butterfly needle designs: Key manufacturers are focusing on developing advanced butterfly needle designs such as safety butterfly needles with sharps injury prevention features. The launch of ergonomic needle designs is gaining traction among healthcare providers.

Global Butterfly Needles Market Opportunities

•  Increasing demand from emerging countries: The improving healthcare infrastructure and rising healthcare expenditure in emerging economies such as China, India, Brazil, and Southeast Asia is creating lucrative growth opportunities for butterfly needle manufacturers. The expanding patient pool in these countries is driving the product demand for butterfly needles.

•  Rising adoption of safety needle devices: The growing awareness of needlestick injuries is fueling the adoption of safety butterfly needle devices for integrated sharps injury prevention features. Key players are focusing on new product launches to capitalize on this opportunity. Moreover, The Centers for Disease Control and Prevention (CDC), 2020, estimates that each year 385,000 needlestick injuries (NSIs) and other sharps-related injuries are sustained by hospital-based healthcare personnel.

• Technological advancements in needle size variants: The introduction of smaller, non-coring butterfly needles which are designed for pediatric and geriatric patients is expected to create new revenue opportunities due to the rising geriatric population and pediatric healthcare needs.

• Growing use in home healthcare setting: Increasing use of butterfly needles for home infusion and dialysis therapies is expected to widen the consumer base for manufacturers. Expanding home healthcare services is leading to new product adoption avenues.

Global Butterfly Needles Market Trends

• Integration of advanced safety mechanisms in products: Manufacturers are integrating innovative safety features like needle shields, retractable needles, hinged caps, and safety locks in butterfly needle devices to prevent needle stick injuries. Advanced safety butterfly needles are gaining higher traction.

• Development of needle-free injection systems: The growing demand for needle-free injection systems for painless blood drawing and drug delivery is prompting manufacturers to develop advanced needleless injectors. This reduces reliance on conventional needles.

• Focus on improved needle designs and user-friendly features: Key players are launching ergonomically designed butterfly needles which are integrated with user-friendly enhancements like easy grips, 360-degree rotation, and multiple lumens to enhance administration and minimize discomfort.

• Use of plastic and polymer needle materials: The utilization of plastic polymers, polycarbonates, polypropylene, and other advanced materials to manufacture butterfly needle tubing and wings offers durability, flexibility and increased resistance to needle breaks and blockages.

Global Butterfly Needles Market Restrains

• Risk of needlestick injuries: Conventional butterfly needles pose the risk of needlestick injuries which can cause blood-borne pathogen transmission between patients and healthcare workers. This is negatively impacting adoption among healthcare facilities.
• Low penetration in underdeveloped regions: The lack of advanced healthcare infrastructure, limited patient awareness, and lower healthcare budgets are hampering butterfly needle adoption in underdeveloped regions and rural areas of emerging economies.

Presence of alternative modes of blood collection

• The availability of alternative blood collection methods like vacuum tubes, syringes, capillary tubes is limiting the universal adoption of butterfly needle devices across all patient demographics.
• Counterbalance: The use of conventional butterfly needles should be proper so that no pathogen transmission takes place among the healthcare workers. Proper awareness program needs to be carried out in the underdeveloped regions so that it can easily adopt in those areas. Options for alternative modes of blood collection should also be universally available.

Figure 2. Global Butterfly Needles Market Share (%), By Needle Length, 2023

To learn more about this report, request a free sample copy

Recent Developments

New Product Launches

• In January 2022, Sol-Millennium Inc., a manufacturer of needles, syringes, and blood collection devices, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its proprietary Sol-Guard Safety Pull Button Blood Collection Set, the newest safety device in the company's blood collection portfolio. The blood collection set features spring-activated needle retraction technology, which is designed to minimize the risk of accidental needlesticks and exposure to blood-borne pathogens.
• In June 2021, ILife India, launched pandemic-safe iSafety butterfly needles to prevent infections for healthcare staff administering IVs or drawing blood samples.
• In June 2020, BD (Becton, Dickinson and Company), a medical technology company, announced that it obtained the CE mark in Europe for the BD Vacutainer UltraTouch Push Button Blood Collection Set (BCS) with Preattached Holder. Moreover, the product with preattached holder will be launched in the U.S. under the previously cleared BD Vacutainer UltraTouch Push Button BCS
• In January 2018, Greiner Bio-One launched the world's first safety blood collection butterfly needle VACUETTE® Quatro Catheter to prevent needlestick injuries.

Acquisitions and Partnerships

• In March 2022, ICU Medical Inc., a medical device company, acquired Smiths Medical from Smiths Group plc, a British, multinational, diversified engineering business. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies would create a leading infusion therapy company with estimated combined revenues of approximately US$ 2.5 billion.

Top Companies in Butterfly Needles Market

• Alshifa Medical Syringes
• Asahi Kasei Medical
• Beijing PuYi Medical Technology Co
• Bionic Medizintechnik
• Biosigma SPA
• Changzhou Zener Medtec
• Demophorius Healthcare
• Dialife SA
• Epimed
• B. Medical
• Farmasol
• HeBei ChaoRan Medical Instruments
• HWTAi
• Jiangsu Eyoung Medical Devices
• Kawasumi
• KB Medical Group
• Lepu Medical Technology
• Micsafe Medical
• Nanchang Kindly Meditech
• Nemoto
• Nipro
• NxStage Medical
• Oscar Boscarol
• PakuMed Medical Products
• Sunrise Medical Technology

*Definition: A butterfly needle is a device used to access a vein for drawing blood or giving medications. Some medical professionals call a butterfly needle a “winged infusion set” or a “scalp vein set.” The set gets its name because there are plastic “wings” on either side of a hollow needle used to access the vein.